What is KMTS's current stock price?

KMTS (Kestra Medical Technologies, Ltd.) is currently trading at $21.64 with a market cap of $1.26B.

What sector is Kestra Medical Technologies, Ltd. in?

Kestra Medical Technologies, Ltd. (KMTS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.

Is KMTS a good stock to buy?

Analysts have a Buy consensus on KMTS with a price target of $28.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

KMTS Kestra Medical Technologies, Ltd.

Healthcare

$21.64+0.37%ClosedMarket Cap: $1.26B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

3.97

P/S

15.09

EV/EBITDA

-7.63

DCF Value

$4.28

FCF Yield

-9.5%

Div Yield

0.0%

Margins & Returns

Gross Margin

48.8%

Operating Margin

-171.5%

Net Margin

-173.0%

ROE

-68.8%

ROA

-38.2%

ROIC

-42.7%

Financials

View All

Period	Revenue	Net Income	EPS
Q3 null	$24.6M	$-34.2M	$—
Q2 null	$22.6M	$-32.8M	$—
Q1 null	$19.4M	$-25.8M	$—
Q4 null	$17.2M	$-52.1M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$28.00

Target (Median)

$29.00

Target Range

$24.00 - $30.00

1 Strong Buy5 Buy1 Hold0 Sell0 Strong Sell

Goldman SachsNeutral

2026-04-09

BTIGBuy

2026-04-07

Goldman SachsNeutral

2025-12-15

Wells FargoOverweight

2025-12-12

Piper SandlerOverweight

2025-12-12

Trading Activity

Insider Trades

View All

Webster Brian Danieldirector, officer: See Remarks

SellMon May 18

Webster Brian Danieldirector, officer: See Remarks

SellMon May 18

Webster Brian Danieldirector, officer: See Remarks

SellThu Apr 16

COHEN RAYMOND Wdirector

BuyMon Mar 30

Webster Brian Danieldirector, officer: See Remarks

SellThu Mar 19

Latest News

Kestra Medical Technologies Named Finalist for 2026 GeekWire “Deal of the Year”GlobeNewsWire · Wed Mar 25

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

Exchange

—

Beta

0.83

Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. The company develops and commercializes Cardiac Recovery System platform, a system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution. Its Cardiac Recovery System platform is the ASSURE WCD, a wearable cardioverter defibrillator (WCD) used to protect patients at an elevated risk of sudden cardiac arrest (SCA). The company's Cardiac Recovery System platform also includes a suite of integrated digital solutions and services that enable enhanced patient and provider engagement and oversight with the objective of improving patient outcomes. The company was founded in 2014 and is based in Kirkland, Washington.

Peers

EVO